Cargando…

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes

BACKGROUND: Recently, several studies reported that the cancer incidence in type 2 diabetes patients is higher than in the general population. Although a number of risks are shared between cancer and diabetes patients, there have been few studies of its correlation. We evaluated the influences of se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Hyun Hee, Moon, Jun Sung, Yoon, Ji Sung, Lee, Hyoung Woo, Won, Kyu Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638223/ https://www.ncbi.nlm.nih.gov/pubmed/23641353 http://dx.doi.org/10.4093/dmj.2013.37.2.125

Ejemplares similares

Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes
por: Chung, Seung Min, et al.
Publicado: (2018)

Author Correction: Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes
por: Chung, Seung Min, et al.
Publicado: (2018)

Diagnostic Accuracy of 64-Slice MDCT Coronary Angiography for the Assessment of Coronary Artery Disease in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Peripheral Arterial Stiffness Increases the Risk of Progression of Renal Disease in Type 2 Diabetic Patients
por: Lim, Tae Hoon, et al.
Publicado: (2020)

A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index
por: Kim, Ho Jin, et al.
Publicado: (2017)

Risk factors affecting amputation in diabetic foot
por: Lee, Jun Ho, et al.
Publicado: (2020)

Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus
por: Cho, Jae Ho, et al.
Publicado: (2016)

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
por: Moon, Jun Sung, et al.
Publicado: (2013)

Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study
por: Chung, Seung Min, et al.
Publicado: (2018)

The Changes of Trends in the Diagnosis and Treatment of Diabetic Foot Ulcer over a 10-Year Period: Single Center Study
por: Kim, Choong Hee, et al.
Publicado: (2018)

Perfluorinated compounds in adults and their association with fasting glucose and incident diabetes: a prospective cohort study
por: Chung, Seung Min, et al.
Publicado: (2022)

Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: Oh, Tae Jung, et al.
Publicado: (2019)

Predicting Mortality of Critically Ill Patients by Blood Glucose Levels
por: Park, Byung Sam, et al.
Publicado: (2013)

The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36
por: Yoon, Ji Sung, et al.
Publicado: (2016)

Association between diabetes-related factors and clinical periodontal parameters in type-2 diabetes mellitus
por: Kim, Eun-Kyong, et al.
Publicado: (2013)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Medial Arterial Calcification and the Risk of Amputation of Diabetic Foot Ulcer in Patients With Diabetic Kidney Disease
por: So, Joon Myeong, et al.
Publicado: (2023)

Oxidative stress: link between hypertension and diabetes
por: Moon, Jun Sung, et al.
Publicado: (2017)

Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
por: Chin, Sang Ouk, et al.
Publicado: (2020)

Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
por: Han, Kyung‐Ah, et al.
Publicado: (2018)

Usefulness of Glycated Hemoglobin as Diagnostic Criteria for Metabolic Syndrome
por: Park, Sang Hyun, et al.
Publicado: (2012)

Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance
por: Moon, Jun Sung, et al.
Publicado: (2023)

Pancreatic α-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block
por: Moon, Jun Sung, et al.
Publicado: (2015)

The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus
por: Lee, Ye-Jin, et al.
Publicado: (2018)

The Relationship between Coronary Artery Calcification and Renal Function in Nondialyzed Patients
por: Chang, Jae Hyun, et al.
Publicado: (2012)

Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes
por: Park, Cheol-Young, et al.
Publicado: (2014)

Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus
por: Cho, Young Min, et al.
Publicado: (2010)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

Variation in Serum Creatinine Level Is Correlated to Risk of Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
por: Lee, Chae Bin, et al.
Publicado: (2021)

The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond
por: Moon, Jun Sung, et al.
Publicado: (2020)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Does Metformin Affect The Incidence of Colonic Polyps and Adenomas in Patients with Type 2 Diabetes Mellitus?
por: Cho, Youn Hee, et al.
Publicado: (2014)

Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
por: Hong, Sang‐Mo, et al.
Publicado: (2017)

Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes
por: Lee, Hoyoon, et al.
Publicado: (2019)

Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
por: Min, Kyung-Wan, et al.
Publicado: (2017)

Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
por: Moon, Jun Sung, et al.
Publicado: (2023)

The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus
por: Hashem, Manal Mohammed, et al.
Publicado: (2021)

Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort
por: Kim, Hae Jin, et al.
Publicado: (2018)

Association between diabetic foot ulcer and diabetic retinopathy
por: Hwang, Duck Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qlqscjla1ca28fn4pqpa596clf